These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36733376)

  • 21. Remdesivir-Induced Bradycardia and Mortality in SARS-CoV-2 Infection, Potential Risk Factors Assessment: A Systematic Review and Meta-Analysis.
    Ai MY; Chang WL; Yang CJ
    J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137586
    [No Abstract]   [Full Text] [Related]  

  • 22. Bradycardia and Outcomes in COVID-19 Patients on Remdesivir: A Multicenter Retrospective Study.
    Umeh CA; Maguwudze S; Kaur H; Dimowo O; Naderi N; Safdarpour A; Hussein T; Gupta R
    Cardiol Res; 2023 Jun; 14(3):192-200. PubMed ID: 37304919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete heart block associated with Remdesivir in COVID-19: a case report.
    Selvaraj V; Bavishi C; Patel S; Dapaah-Afriyie K
    Eur Heart J Case Rep; 2021 Jul; 5(7):ytab200. PubMed ID: 34222786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bradycardia Related to Remdesivir During COVID-19: Persistent or Permanent?
    Maheshwari M; Athiraman H
    Cureus; 2021 Nov; 13(11):e19919. PubMed ID: 34956798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remdesivir-associated bradycardia in COVID-19: a rapid review protocol.
    Tian E; Cosme C; Bauzon J; Batra K; Azar F; Schreiber A
    BMJ Open; 2023 May; 13(5):e068564. PubMed ID: 37258075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remdesivir-Associated Significant Bradycardia: A Report of Three Cases.
    Shirvani M; Sayad B; Shojaei L; Amini A; Shahbazi F
    J Tehran Heart Cent; 2021 Apr; 16(2):79-83. PubMed ID: 35082876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns.
    Touafchia A; Bagheri H; Carrié D; Durrieu G; Sommet A; Chouchana L; Montastruc F
    Clin Microbiol Infect; 2021 Feb; 27(5):791.e5-8. PubMed ID: 33647441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Success rate of Remdesivir, Convalescent Plasma, and Tocilizumab in moderate to severe Covid-19 pneumonia: our experience in a tertiary care center.
    Mohanty B; Sunder A; Satyanarayan B; Kumar M; Shukla R; Ahmed A
    J Family Med Prim Care; 2021 Nov; 10(11):4236-4241. PubMed ID: 35136795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-life experience with remdesivir for treatment of hospitalized coronavirus disease 2019 patients: matched case-control study from a large tertiary hospital registry.
    Lucijanić M; Bušić N; Bistrović P; Papić I; Zelenika Margeta M; Babić P; Barčan M; Pasarić A; Mustapić M; Piskač Živković N; Ortner Hadžiabdić M; Lucijanić T; Lukšić I; Baršić B
    Croat Med J; 2022 Dec; 63(6):536-543. PubMed ID: 36597565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of adverse events associated with remdesivir use for coronavirus disease 2019 using real-world data.
    Singh A; Kamath A
    Expert Opin Drug Saf; 2021 Dec; 20(12):1559-1564. PubMed ID: 34328807
    [No Abstract]   [Full Text] [Related]  

  • 31. Remdesivir (VEKLURY) for Treating COVID-19: Guinea Pig Ex Vivo and In Vivo Cardiac Electrophysiological Effects.
    Pilote S; Simard C; Drolet B
    J Cardiovasc Pharmacol; 2022 Oct; 80(4):616-622. PubMed ID: 35881906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remdesivir-Associated Sinus Arrest in COVID-19: A Potential Indication for Close Cardiac Monitoring.
    Gregory GE; Gregory HM; Liaqat H; Ghaly MM; Johnson-Pich KD
    Cureus; 2022 Feb; 14(2):e22328. PubMed ID: 35317046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remdesivir-Induced Bradycardia.
    Kanagala SG; Dholiya H; Jhajj P; Patel MA; Gupta V; Gupta S; Wu SI; Jain R
    South Med J; 2023 Mar; 116(3):317-320. PubMed ID: 36863055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database.
    Gupte V; Hegde R; Sawant S; Kalathingal K; Jadhav S; Malabade R; Gogtay J
    BMC Infect Dis; 2022 Jan; 22(1):1. PubMed ID: 34983406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.
    Lee S; Santarelli A; Caine K; Schritter S; Dietrich T; Ashurst J
    J Am Osteopath Assoc; 2020 Dec; 120(12):926-933. PubMed ID: 33136164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marked Sinus Bradycardia Associated With Remdesivir in COVID-19: A Case and Literature Review.
    Gubitosa JC; Kakar P; Gerula C; Nossa H; Finkel D; Wong K; Khatri M; Ali H
    JACC Case Rep; 2020 Nov; 2(14):2260-2264. PubMed ID: 33163977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bradycardia in Patients With COVID-19: A Calm Before the Storm?
    Amaratunga EA; Corwin DS; Moran L; Snyder R
    Cureus; 2020 Jun; 12(6):e8599. PubMed ID: 32550090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with moderate to severe COVID-19 outcomes on remdesivir according to baseline 4C mortality score.
    Sellers J; Chang J; Jones J; Hintze TD
    Pulm Pharmacol Ther; 2023 Feb; 78():102188. PubMed ID: 36603741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.